In people with chronic obstructive pulmonary disease (COPD), injectable pneumococcal vaccine seems to protect against community-acquired pneumonia and COPD exacerbation, but not against pneumococcal pneumonia. The vaccine does not reduce risk of hospital admission or death but seems to result in fewer people attending the emergency department.